Newsfeeds - Spark Newswire

2 minute read

Sorrento Therapeutics, Inc. Receives Court Approval For $75M Financing In Chapter 11 Case; Hearing For Final Approval Of The Financing Is Currently Set For March 29, 2023

Today, 8:00 PM

Sorrento Therapeutics, Inc. (NASDAQ:SRNE, ", , Sorrento", , )))), a biopharmaceutical company dedicated to the development of life-saving therapeutics to treat cancer, intractable pain, and infectious

SCLX

2 minute read

News

Sorrento Therapeutics, Inc. Receives Court Approval For “First Day” Employee Wages And Cash Management Motions, In Connection With Sorrento’s Chapter 11 Petition From The The U.S. Bankruptcy Court For The Southern District Of Texas

By Happy Mohamed

Today, 8:00 PM

SCLX

4 minute read

Why Boston Beer Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

Today, 8:00 PM

Gainers TravelCenters of America Inc. (NASDAQ: TA) shares jumped 70.5% to $84.32 after BP announced it will acquire the company for $86 per share in cash.

AMAM

2 minute read

Joint Statement By Sorrento Therapeutics, Inc. And Scilex Holding Company On Today’s Isolated Chapter 11 Filing By Sorrento Therapeutics, Inc.

By Happy Mohamed

Today, 8:00 PM

Scilex Holding Company (NASDAQ:SCLX, ", Scilex", )))), a majority-owned subsidiary of Sorrento Therapeutics, Inc. (NASDAQ:SRNE, ", Sorrento", )))) and an innovative revenue-generating company focused on

SCLX

4 minute read

Why Frequency Therapeutics Are Trading Lower By 82%? Here Are Other Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 8:00 PM

Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares jumped 120.5% to $1.02 after jumping over 72% on Friday.

AMV

2 minute read

Movers

12 Health Care Stocks Moving In Monday’s Intraday Session

By Benzinga Insights

Today, 8:00 PM

Gainers Vallon Pharmaceuticals (NASDAQ:VLON) shares moved upwards by 146.5% to $1.14 during Monday’s regular session. As of 12:30…

CELZ

1 minute read

News

Sorrento Therapeutics Subsidiary Scilex Acquires Rights To FDA-Approved ELYXYB in the US and Canada For Acute Treatment Of Migraine

By Benzinga Newsdesk

Today, 8:00 PM

Scilex Holding Company (NASDAQ:SCLX, ", Scilex", )))), a majority-owned subsidiary of Sorrento Therapeutics, Inc. (NASDAQ:SRNE, ", Sorrento", )))), an innovative revenue-generating company focused on

SCLX

2 minute read

Dow Jumps 250 Points; US Jobless Claims Increase Last Week

By Lisa Levin

Today, 8:00 PM

U.S. stocks traded higher this morning, with the Dow Jones jumping around 250 points on Thursday. The Dow traded up 0.75% to 34,204.99 while the NASDAQ rose 1.15% to 12,047.28. The S&P 500 also rose, gaining, 0.75% to 4,148.69.

APP

3 minute read

Nasdaq Tumbles 150 Points; Crude Oil Up 1.5%

By Lisa Levin

Today, 8:00 PM

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping over 150 points on Wednesday. The Dow traded down 0.27% to 34,063.42 while the NASDAQ fell 1.33% to 11,952.51. The S&P 500 also fell, dropping, 0.80% to 4,130.55.

CPRI

1 minute read

News

Scilex Holding Company Announces That Its Majority Stockholder, Sorrento Therapeutics, Has Issued A Supplement To Its Previously Issued “FAQ” Regarding The Dividend Of Scilex Holding Company Common Stock

By Happy Mohamed

Today, 8:00 PM

Scilex Holding Company (NASDAQ:SCLX) announced that its majority stockholder, Sorrento Therapeutics, Inc. (NASDAQ:SRNE, ", Sorrento", )))) today posted a supplement to its previously issued "Frequently

SCLX